BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17901040)

  • 1. Prognosis and treatment outcome in patients with acute myeloid leukemia with t(8;21)(q22;q22).
    Chen CC; Gau JP; Yu YB; Lu CH; Lee KD; You JY
    Adv Ther; 2007; 24(4):907-20. PubMed ID: 17901040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22).
    Wen L; Xia J; Wang Q; Yao H; Xie J; Pan J; Xue Y; Wu D; Chen S
    Int J Hematol; 2015 Aug; 102(2):205-10. PubMed ID: 26040504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of treatment strategy and prognosis on acute myeloid leukemia with chromosome 8 and 21 translocation].
    Shi HX; Jiang B; Qiu JY; Lu XJ; Fu JF; Wang DB; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):481-4. PubMed ID: 16383240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.
    Giles FJ; Kanemaki TJ; Schreck RR; Qasabian L; Fuerst MP; Lim SW
    Cancer Genet Cytogenet; 1998 Jul; 104(1):66-9. PubMed ID: 9648562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics of acute myeloid leukemia with t (16;21) (p11;q22):nine cases report and literature review].
    Ouyang M; Xu LP; Wang Y; Zhu HH; Qin YZ; Lai YY; Liu YR; Jiang B; Huang XJ; Jiang H
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):210-5. PubMed ID: 27033758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].
    Zhu CY; Yang H; Niu JH; Zhang Q; Xie XL; Wang LJ; Zhu HY; Yao ZL; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):950-6. PubMed ID: 25130809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
    Byrd JC; Weiss RB; Arthur DC; Lawrence D; Baer MR; Davey F; Trikha ES; Carroll AJ; Tantravahi R; Qumsiyeh M; Patil SR; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 Feb; 15(2):466-75. PubMed ID: 9053467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukaemia with t(8;21)(q22;q22.3) and loss of the X chromosome.
    Mohamed M; Dun K
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26250367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
    Gustafson SA; Lin P; Chen SS; Chen L; Abruzzo LV; Luthra R; Medeiros LJ; Wang SA
    Am J Clin Pathol; 2009 May; 131(5):647-55. PubMed ID: 19369623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).
    Wang H; Yang W; Shao H; Zhang J; Qi L; Liao A; Li Y; Liu Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):95-8. PubMed ID: 19100512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
    Schoch C; Haase D; Haferlach T; Gudat H; Büchner T; Freund M; Link H; Lengfelder E; Wandt H; Sauerland MC; Löffler H; Fonatsch C
    Leukemia; 1996 Aug; 10(8):1288-95. PubMed ID: 8709633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.
    Zhu HH; Zhang XH; Qin YZ; Liu DH; Jiang H; Chen H; Jiang Q; Xu LP; Lu J; Han W; Bao L; Wang Y; Chen YH; Wang JZ; Wang FR; Lai YY; Chai JY; Wang LR; Liu YR; Liu KY; Jiang B; Huang XJ
    Blood; 2013 May; 121(20):4056-62. PubMed ID: 23535063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
    Grimwade D; Hills RK; Moorman AV; Walker H; Chatters S; Goldstone AH; Wheatley K; Harrison CJ; Burnett AK;
    Blood; 2010 Jul; 116(3):354-65. PubMed ID: 20385793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of high-dose cytarabine for patients with t(8;21) AML and with normal karyotype AML].
    Li HY; Yue H; Wei XD; Zhu XH; Zhang YL; Zhang LN; Liu YY; Wang P; Fang BJ; Li YF; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):110-2. PubMed ID: 18681312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia with new complex t(8;21;22) induced hemophagocytic lymphohistiocytosis: A case report.
    Wu Y; Xu J; Shen K; Ji J; Yang C; Liu T; Xiang B
    Medicine (Baltimore); 2018 Nov; 97(44):e12762. PubMed ID: 30383631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MICM characteristics and typing diagnosis in acute myelogenous leukemia patients (AML-M2) with complex karyotype t (2;21;8)(p12;q22;q22)].
    Ma Y; Tong HX; Deng X; Zhao Y; Liu ZG; Zhang JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):12-6. PubMed ID: 19236738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
    Tavernier E; Le QH; Elhamri M; Thomas X
    Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia (AML-M1) with multiple trisomies and t(8;21)(q22;q22).
    Köhler M; Johansson B; Ludvigsson J; Aman P; Heim S; Mitelman F
    Cancer Genet Cytogenet; 1994 Mar; 73(1):79-81. PubMed ID: 8174079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.